tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Magenta Therapeutics's activity chart (see below) currently has 13 price targets and 18 ratings on display.
Analysts average stock forecasts to be materialized ratio is 57.78% with an average time for these price targets to be met of 228.47 days.
Most recent stock forecast was given by from WEDBUSH on 26-Jan-2023. First documented stock forecast 25-Mar-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Jun-2021
3 years 7 months 19 days ago
(26-Jan-2023)
1/2 (50%)
$-3.28 (-52.23%)
329
Hold Since 26-Jan-2023
$3
$-8.19 (-73.19%)
3 years 7 months 19 days ago
(26-Jan-2023)
1/2 (50%)
$-4.04 (-57.39%)
406
Buy Since 08-Mar-2022
$2
4 years 20 days ago
(25-Aug-2022)
1/2 (50%)
$-16.72 (-89.32%)
287
Buy Since 07-Jan-2021
$128
$116.81 (1043.88%)
4 years 4 months 27 days ago
(18-Apr-2022)
0/2 (0%)
$97.28 (316.67%)
Buy Since 01-Dec-2021
$128
$116.81 (1043.88%)
$272
4 years 4 months 27 days ago
(18-Apr-2022)
0/3 (0%)
$97.28 (316.67%)
What is MGTA (Magenta Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MGTA (Magenta Therapeutics)?
Which analyst has the most public recommendations on MGTA (Magenta Therapeutics)?
Which analyst is the currently most bullish on MGTA (Magenta Therapeutics)?
Which analyst is the currently most reserved on MGTA (Magenta Therapeutics)?
